MADRIGAL PHARMACEUTICALS, INC.

Madrigal Pharmaceuticals, Inc.

Biotechnology Healthcare West Conshohocken, PA, United States MDGL (NMS)

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has MADRIGAL PHARMACEUTICALS, INC. had layoffs?
No layoff events have been recorded for MADRIGAL PHARMACEUTICALS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does MADRIGAL PHARMACEUTICALS, INC. have?
MADRIGAL PHARMACEUTICALS, INC. has approximately 528 employees.
What industry is MADRIGAL PHARMACEUTICALS, INC. in?
MADRIGAL PHARMACEUTICALS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is MADRIGAL PHARMACEUTICALS, INC. a publicly traded company?
Yes, MADRIGAL PHARMACEUTICALS, INC. is publicly traded under the ticker symbol MDGL on the NMS. The company has a market capitalization of approximately $13.60 billion.
Where is MADRIGAL PHARMACEUTICALS, INC. headquartered?
MADRIGAL PHARMACEUTICALS, INC. is headquartered in West Conshohocken, PA, United States at Four Tower Bridge, West Conshohocken, PA 19428, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.